Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT05328778
PHASE4
Pharmacokinetics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade in Patients During Laparoscopic Surgery
Sponsor: Guangzhou General Hospital of Guangzhou Military Command
View on ClinicalTrials.gov
Summary
The purpose of this study is to illustrate pharmacokinetics of sugammadex in reversal of vecuronium-induced neuromuscular blockade in patients during laparoscopic surgery
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2022-04-14
Completion Date
2026-04-01
Last Updated
2026-04-20
Healthy Volunteers
No
Conditions
Interventions
DRUG
Sugammadex
Each patient received a single dose administration of sugammadex 2mg/kg according to the ideal body weight (IBW) at reappearance of the second twitch of the train-of-four (TOF).
Locations (1)
Guangzhou Military Region General Hospital, Department of Anesthesiology
Guangzhou, Guangdong, China